| http://www.w3.org/ns/prov#value | - Subjects: Trials of antiplatelet therapy versus control included about 70 000 ???high risk??? patients (that is, with some vascular disease or other condition implying an increased risk of occlusive vascular disease) and 30 000 ???low risk??? subjects from the general population.
|
